Multidisciplinary therapeutic strategy with appropriate timing and modalities for treating cervicofacial lymphatic malformations in children
Topic overview
This study describes a multidisciplinary treatment approach for cervicofacial lymphatic malformations in 53 pediatric patients, emphasizing airway management and watchful waiting in infants, followed by OK-432 sclerotherapy, sirolimus therapy, and selective surgery for persistent lesions. The strategy achieved moderate to excellent outcomes in most patients while minimizing early intervention risks.
Key takeaways
- Infants with cervicofacial lymphatic malformations benefit from airway-first management with wait-and-see approach for spontaneous regression
- OK-432 sclerotherapy after age 1 year combined with selective surgery achieves moderate-to-excellent outcomes in majority of pediatric cases
- Sirolimus demonstrates efficacy for residual lesions showing moderate shrinkage and bleeding control in refractory cases
- Early sclerotherapy in infants carries significant airway risks; tracheostomy may be required but can often be reversed after treatment
- Multidisciplinary timing-based strategy (observation, sclerotherapy, sirolimus, surgery) significantly improves quality of life in pediatric CFLMs
Keywords
Hashtags
Full article text
Full article text not available for this entry
How to cite: GlobalCastMD. Multidisciplinary therapeutic strategy with appropriate timing and modalities for treating cervicofacial lymphatic malformations in children. GlobalCastMD Medical Library. 2024-12-19. https://dev.library.globalcastmd.com/article/9544?via_space=staycurrentmd
Comments